Ablynx to get milestones from Wyeth and Boehringer Ingelheim

Ablynx NV is set to receive payments totalling €5.72 million from Wyeth Pharmaceuticals and Boehringer Ingelheim following the achievement of milestones in separate collaborations with the two companies